Ceragenix Pharmaceuticals

Rodman & Renshaw 3rd Annual Global Healthcare Conference 2006
Genetic Engineering News - May 15 at 5:15 EDT Ceragenix Pharmaceuticals, Inc. (OTCBB: CGXP - News) is a biopharmaceutical company that discovers, develops and commercializes novel anti-infective drugs based on its proprietary class of compounds, Ceragenins(TM) (or CSAs

Colorado business, 5/2
Denver Post - Ceragenix Pharmaceuticals Inc. , a Denver-based biopharmaceutical company, announced Monday that Steven Porter, its chairman and chief executive, will make a presentation at the Rodman & Renshaw third annual Global Healthcare Conference on May 15 in

Latest News
dBusinessNews.com - DENVER -- America's best respected radio frequency identification (RFID) consulting Denver: FDA Grants Ceragenix's Request for Cerashield(TM) to be Reviewed as a Device; Ceragenix to Seek Expedited Review DENVER -- Ceragenix Pharmaceuticals, Inc

Ceragenix Enters Into Research and Development Agreement Drugs
MSN MoneyCentral - Ceragenix Pharmaceuticals, Inc., a biopharmaceutical company focused on infectious disease and dermatology, today announced that it has entered into a research and development agreement with an internationally recognized research laboratory to